|
List of Jounal Titles
A to Z index of Journal Title. Choose a letter.
Folia Pharmacologica Japonica
121
- Therapeutic strategy for fibrotic diseases by regulating the expression of collagen-specific molecular chaperone HSP47.
- Molecular chaperone inducers in medicine and diseases.
- Novel physiological roles of low molecular weight HSPs.
- Small heat shock proteins participate in the regulation of cellular aggregates of misfolded protein.
- Molecular chaperone HSP90 as a novel target for cancer chemotherapy.
- ORP150 (150 kDa oxygen regulated protein) suppressed neuronal cell death.
- Possible participation of advanced glycation endproducts and their receptor system in the development of diabetic vascular complications.
- Pharmacological profile of anti-human TNF.ALPHA. monoclonal antibody, infliximab (Remicade).
- Maxacalcitol, a medicine for secondary hyperparathyroidism (2.DEG. HPT).
2
- Recent advances in the study of endothelium-dependent hyperpolarizing factor (EDHF).
- New expansion of endothelin research: Perspectives for clinical application of endothelin-receptor antagonists.
- Regulatory role of mechanical stress response in cellular function: Development of new drugs and tissue engineering.
- Detections of matrix metalloproteinases activities and localization by Film in situ zymography (FIZ).
- Preclinical and clinical profile of imatinib mesilate, a potent protein-tyrosine kinase inhibitor for CML therapy.
3
- Analyses of Ca-related ion channel currents and their involvement in Ca mobilization in smooth muscle and endothelial cells.
- Rho-mediated signal transduction and its physiological roles.
- Mechanism of production and release of tumor necrosis factor implicated in inflammatory diseases.
- Analysis of central synaptic transmission with the slice-patch-clamp technique.
- Biomedical imaging in pharmacology with nuclear medical imaging methodologies: Positron emission tomography (PET) and single photon emission computed tomography (SPECT).
4
- Ryanodine receptor and junctional membrane structure.
- N-type Ca2+ channel.
- TRP channels: formation of signal complex and regulation of cellular functions.
- Alternative splicing of CaV2 genes and their functional significance.
- Inositol 1,4,5 trisphosphate (IP3) receptor.
- Analysis of the molecular mechanisms controlling synaptic transmission by patch-clamp recording in brainstem slices.
- Intermittent microinjection method in freely-moving rats and its application to neuropharmacology.
5
- New insights into neural mechanisms controlling the micturition reflex
- Regulation by autonomic nerves of bladder neck sphincter function-mainly on inhibitory NANC nerves-
- Pharmacological analysis of neurotransmitters contributing to lower urinary tract function
- Molecular and electrophysiological investigation of ATP-sensitive K+ channels in lower urinary tract function: the aims for clinical treatment of unstable detrusor
- Molecular biological researches of the lower urinary tract function
- Pathophysiology of the overactive bladder and its pharmacological treatment
- Na+ overload-induced mitochondrial dysfunction in myocardial ischemia/reperfusion injury
- Real-time detection of neurotransmitter release and its spatial distribution
- Real-time imaging of local Ca2+ signaling in single neurons
6
- Draft ICH guideline S7B: Guideline on safety pharmacology studies for assessing the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals.
- Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels.
- Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models.
- Genetic background predisposing the drug-induced long QT syndrome.
- Physiological functions of protease-activated receptor-2.
- Analysis of PKC targeting mechanism using PKC fused with fluorescent proteins.
- Protein transduction by poly-arginine.
- The model of stroke induced by microsphere embolism in rats.
- Antibacterial property and clinical effect of gatifloxacin, a novel quinolone antibacterial agent.
1
122
- Altered behavioral response to centrally acting drugs in mice lacking PACAP.
- Therapeutic gene clusters as drug action mechanisms
- Adrenergic receptor signaling and regulation.
- Molecular pharmacology of sarpogrelate.
- Functional expression of machineries for glutamate signaling in bone.
- Modulation of excitability in midbrain dopaminergic neurons and skeletal muscles by neuronal nicotinic receptors: Perspectives from knockout mice
- Signal transduction and development of drug for brain ischemic insult.
- Probing of the target molecules of Rho-kinase and its function in neuronal cells.
- Functional differentiation of neural stem cells into endothelial cells.
- Functional analysis of SIR2.
- Mechanical stress and cerebrovascular response - Resemblance to cerebral vasospasm after subarachnoid hemorrhage.
- Molecular mechanisms for cAMP-independent activation of MaxiK channel: G protein direct channel regulation and contribution to the tuning of vascular smooth muscle tone.
- Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta.
- Changes in the contractility of the NIH3T3 fibroblast induced by the over-expression of CPI-17.
- Mechanism of the intestinal dysmotility in the inflammatory bowel diseases: Possible involvement of muscularis resident macrophages
- Analysis of airway hyperresponsiveness using in vitro contraction model.
- .BETA.-Adrenoceptor subtypes involved in relaxations of guinea-pig gastrointestinal smooth muscles: distribution and signaling pathway of .BETA.3-adrenoceptors.
- Activation of smooth muscle myosin by the non-kinase role of myosin light chain kinase.
- Reserpine-induced supersensitivity and .ALPHA.1-adrenoceptor subtypes
- Functional difference of prokinetics depending on subtypes and localization of receptor in alimentary tract.
- Regulation of the drug-sensitivity of anion channels via phosphorylation.
- Role of PGI2 in ectopic bone formation of spinal ligaments.
- New target for the inhibitors of gastric acid secretion. Inhibition of myosin and actin activities via the apical membrane of parietal cells in dogs.
- A Potential of Positron Emission Tomography in the Drug Development of Non-sedative Antihistamines.
- Candidate genes or compounds for therapeutic tools against methamphetamine and/or morphine-induced dependence
- Thymidine phosphorylase inhibits apoptosis induced by anticancer agents
1
- Amyloid-.BETA. peptide metabolism and Alzheimer's disease
- Atopic dermatitis and cathepsin E
- Calpain and pathology in view of structure-function relationships
- The protein quality control and neurodegeneration
- Gingipains as the determinants of periodontopathogenicity
- Host cellular proteases trigger the infectivity of the influenza virus in the airway and brain
- Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier
- Recent advances in cardiac protection
- An overview of acetic acid ulcer models and their utility for drug screening
- Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine
2
- Role of chymase in vascular diseases and the efficacy of chymase inhibitor.
- Pharmacological study on the effects of the adenosine uptake inhibitor KF24345 on inflammatory diseases.
- Brain microdialysis of isolation-reared mice under freely-moving conditions.
- Profile of the anti-tumor effects of amrubicin, a completely synthetic anthracycline.
- Pharmacological profile of a specific neutrophil elastase inhibitor, Sivelestat sodium hydrate.
- Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate.
3
- Pain and QOL-morphine-tolerance and morphine-resistant neuropathic pain.
- Ionic mechanisms underlying the regulation of cell proliferation, differentiation and death.
- Regulation of psychomotor functions by dopamine: integration of various approaches.
- Contribution of diabetic research to versatile strategies for the treatment of diabetes mellitus.
- Roles of biologically active peptide in regulation of feeding behavior and energy homeostasis.
- Molecular and functional diversity of ATP-sensitive K+ channels: the pathophysiological roles and potential drug targets.
- Pharmacology of excitatory amino acid transporters (EAATs and VGLUTs).
- Pharmacological action and clinical aspects of salmeterol.
4
- The mechanisms by which PPAR.GAMMA. and adiponectin regulate glucose and lipid metabolism.
- Role of PPAR.GAMMA. in the development of the central nervous system.
- PPAR.GAMMA.-gene therapy using an adenovirus vector for inflammatory bowel disease.
- The role of PPAR.GAMMA. in the onset of type 2 diabetes.
- Role of PPAR.GAMMA. in inflammatory response related to mast cells.
- Identification of intracellular regulatory protein for ion channel using yeast two-hybrid system.
- Antifungal activity and clinical efficacy of micafungin sodium (Funguard).
- Pharmacological and clinical profile of exemestane (Aromasin), a novel irreversible aromatase inhibitor.
5
- Basic arrhythmogenic mechanisms in both inherited and acquired long QT syndrome.
- Various functions of ClC-type Cl- channels.
- Pathophysiological roles of the prostanoids in the cardiovascular system: Studies using mice deficient in prostanoid receptors.
- Roles of histamine receptors in pain perception: A study using receptors gene knockout mice.
- Pharmacological education under the Medical Education Model Core Curriculum.
- Teaching Pharmacology in 2010 - new knowledge, new tools, new attitudes.
- Lipid rafts and their analytical methods.
- In vivo functional analysis of the neuropeptide PACAP using gene-targeted mice.
- The dissociation of paratracheal ganglion neurons and its application to neuropharmacology.
- Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients.
6
- Tyrosine kinase as molecular target of anti-tumor drug.
- Tyrosine kinase inhibitor as a therapeutic drug for chronic myelogenous leukemia and gastrointestinal stromal tumor.
- EGFR tyrosine kinase inhibitor "gefitinib (Iressa)" for cancer therapy.
- VEGF-receptor inhibitors for anti-angiogenesis.
- Development of HER2-specific humanized antibody Herceptin (trastuzumab).
- Recent advances in the study of AMPA receptors.
- Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy.
- Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker.
- Pharmacological and clinical properties of Xeloda (Capecitabine), a new oral active derivative of fluoropyrimidine
| Copyright (c) 2006-2007 Japan Science and Technology Agency. All Rights Reserved. | |
